Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.43M 1.33M 1.24M 2.32M 155M 2.34M 15.76M 6.13M 76.22M 6.16M 6.03M 265M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.1M 6.57M 6.13M 11.51M 768M 11.6M 78.08M 30.38M 378M 30.52M 29.86M 1.31B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%0.00%0.00% - 3.65K
+0.32%-2.41%+43.01%+140.80% 980B
+1.27%-1.85%+52.85%+39.65% 550B
+6.25%+3.80%+25.17%+67.39% 382B
-0.06%-3.09%+23.33%+16.78% 316B
+0.42%-1.28%+27.89%+14.71% 272B
+1.67%-1.47%+26.76%+32.88% 268B
+2.39%+4.42%-36.96%-45.12% 199B
+2.11%-1.66%+26.53%+50.10% 182B
+0.90%+0.46%+17.59%+59.86% 154B
Average +991.50%-2.43%+20.62%+41.89% 330.23B
Weighted average by Cap. +1.46%-3.50%+31.22%+64.49%

Financials

2007 2008
Net sales 23.47M 20.5M 18.97M 17.7M 33.23M 2.22B 33.48M 225M 87.7M 1.09B 88.1M 86.19M 3.79B 25.96M 22.68M 20.98M 19.58M 36.76M 2.45B 37.03M 249M 97.01M 1.21B 97.47M 95.35M 4.19B
Net income -20.86M -18.23M -16.86M -15.74M -29.54M -1.97B -29.76M -200M -77.95M -969M -78.31M -76.61M -3.37B -4.01M -3.5M -3.24M -3.02M -5.67M -379M -5.71M -38.47M -14.97M -186M -15.04M -14.71M -647M
Net Debt 18.79M 16.42M 15.19M 14.18M 26.61M 1.78B 26.81M 180M 70.22M 873M 70.55M 69.02M 3.03B 6.49M 5.67M 5.24M 4.89M 9.19M 613M 9.26M 62.32M 24.25M 301M 24.36M 23.83M 1.05B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!